Minimal Important and Detectable Differences of Respiratory Measures in Outpatients with AECOPD †

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 15, Issue 5, 2018, Pages 479-488

  Oliveira, Ana ^a,b   Machado, Ana ^b   Marques, Alda ^b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Exacerbations; interpretability; measurement properties; respiratory interventions

Indexed keywords

ABNORMAL RESPIRATORY SOUND; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CRACKLE; DISEASE EXACERBATION; DRUG THERAPY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; MINIMUM DETECTABLE CHANGE; OBSERVATIONAL STUDY; OUTPATIENT; OXYGEN SATURATION; PRIORITY JOURNAL; AMBULATORY CARE; ECONOMICS; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PORTUGAL; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SEVERITY OF ILLNESS INDEX; SPIROMETRY; UNIVERSITY HOSPITAL;

OXYGEN;

AGED; AMBULATORY CARE; DISEASE PROGRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALS, UNIVERSITY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTPATIENTS; OXYGEN; PORTUGAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SOUNDS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STATISTICS, NONPARAMETRIC; SURVEYS AND QUESTIONNAIRES;

EID: 85058088580     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412555.2018.1537366     Document Type: Article

References (52)

1. Boer L, Bischoff E, Borgijink X, Vercoulen J, Akkermans R, Kerstjens H, Assendelft W, Schermer T. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study. NPJ Prim Care Respir Med. 2018;28(1):12
2. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. doi:10.1164/ajrccm.161.5.9908022
3. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235–245. doi:10.2147/ceor.s34321
4. Anzueto A. Impact of exacerbations on COPD. Eur Respir Rev. 2010;19(116):113–118. doi:10.1183/09059180.00002610
5. Viniol C, Vogelmeier CF. Exacerbations of COPD. Eur Respir Rev. 2018;27(147). doi:10.1183/16000617.0103-2017
6. Wedzicha JAEC-C, Miravitlles M, Hurst JR, Calverley PM, Albert RK, Anzueto A, Criner GJ, Papi A, Rabe KF, Rigau D, et al. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017;49(3). doi:10.1183/13993003.00791-2016
7. Oliveira AL, Marques AS. Outcome measures used in pulmonary rehabilitation in patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review. Phys Ther. 2018;98(3):191–204. doi:10.1093/ptj/pzx122
8. Brożek JL, Guyatt GH, Schünemann HJ. How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health Qual Life Outcomes. 2006;4:69. doi:10.1186/1477-7525-4-69
9. Tsai C-L, Hodder RV, Page JH, Cydulka RK, Rowe BH, Camargo CA. The short-form chronic respiratory disease questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol. 2008;61(5):489–497. doi:10.1016/j.jclinepi.2007.07.003
10. Kon SS, Canavan JL, Jones SE, Nolan CM, Clark AL, Dickson MJ, Haselden BM, Polkey MI, Man WD. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203. doi:10.1016/s2213-2600(14)70001-3
11. The Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease–2018 Report. The Global Initiative for Chronic Obstructive Lung Disease, Inc.; 2018.,
12. Fernández-Villar A, Represas-Represas C, Mouronte-Roibás C, Ramos-Hernández C, Priegue-Carrera A, Fernández-García S, López-Campos JL. Reliability and usefulness of spirometry performed during admission for COPD exacerbation. PloS One. 2018;13(3):e0194983
13. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26(3):420–428. doi:10.1183/09031936.05.00136304
14. de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM. Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes. 2006;4:54. doi:10.1186/1477-7525-4-54
15. Oliveira A, Sen I, Kahya YP, Afreixo V, Marques A. Computerised respiratory sounds can differentiate smokers and non-smokers, J Clin Monit Comput. 2017;31(3):571–580
16. Jones PW, Harding G, Wiklund I, Berry P, Tabberer M, Yu R, Leidy NK. Tests of the responsiveness of the COPD assessment test following acute exacerbation and pulmonary rehabilitation. Chest. 2012;142(1):134–140. doi:10.1378/chest.11-0309
17. Kocks JW, Tuinenga MG, Uil SM, van den Berg JW, Stahl E, van der Molen T. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7:62. doi:10.1186/1465-9921-7-62
18. Soler-Cataluna JJ, Alcazar-Navarrete B, Miravitlles M. The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis. 2014;9:1397–1405. doi:10.2147/copd.S71370
19. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
20. Borg G. Borg’s perceived exertion and pain scales. Champaign, IL: Human Kinetics; 1998
21. Doherty DE, Belfer MH, Brunton SA, Fromer L, Morris CM, Snader TC. Chronic obstructive pulmonary disease: consensus recommendations for early diagnosis and treatment. J Fam Pract. 2006;55(11):S1–S8
22. Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010;5(3):202–210. doi:10.1186/2049-6958-5-3-202
23. Meek PM, Lareau SC. Critical outcomes in pulmonary rehabilitation: assessment and evaluation of dyspnea and fatigue. J Rehabil Res Dev. 2003;40(5 Suppl 2):13–24
24. Taplidou SA, Hadjileontiadis LJ. Wheeze detection based on time-frequency analysis of breath sounds. Comput Biol Med. 2007;37(8):1073–1083
25. S.Huq, Z.Moussavi. Automatic breath phase detection using only tracheal sounds. Paper presented at: Engineering in Medicine and Biology Society (EMBC), 2010 Annual International Conference of the IEEE; 2010
26. Pinho C, Oliveira A, Jácome C, Rodrigues JM, Marques A. Integrated approach for automatic crackle detection based on fractal dimension and box filtering. IJRQEH. 2016;5(4):34–50
27. Oliveira A, Lage S, Rodrigues J, Marques A. Reliability, validity and minimal detectable change of computerized respiratory sounds in patients with chronic obstructive pulmonary disease. Clin Respir J. 2017. doi:10.1111/crj.12745
28. Jacome C, Marques A. Computerized respiratory sounds are a reliable marker in subjects with COPD. Respir Care. 2015;60(9):1264–1275. doi:10.4187/respcare.03922
29. Jácome C, Oliveira A, Marques A. Computerized respiratory sounds: a comparison between patients with stable and exacerbated COPD. Clin Respir J. 2017;11(5):612–620. doi:doi:10.1111/crj.12392
30. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
31. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518–624. doi:10.1164/rccm.166.4.518
32. Aggarwal R, Ranganathan P. Common pitfalls in statistical analysis: the use of correlation techniques. Perspect Clin Res. 2016;7(4):187–190. doi:10.4103/2229-3485.192046
33. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109. doi:10.1016/j.jclinepi.2007.03.012
34. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hellsdale, NJ: Lawrence Earlbaum Associates; 1988
35. Haley SM, Fragala-Pinkham MA. Interpreting change scores of tests and measures used in physical therapy. Phys Ther. 2006;86(5):735–743. doi:10.1093/ptj/86.5.735
36. Sant'Anna T, Donaria L, Furlanetto KC, Morakami F, Rodrigues A, Grosskreutz T, Hernandes NA, Gosselink R, Pitta F. Development, validity and reliability of the londrina activities of daily living protocol for subjects with COPD. Respir Care. 2017;62(3):288–297. doi:10.4187/respcare.05058
37. Mahler DA, Ward J, Waterman LA, McCusker C, ZuWallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest. 2009;136(6):1473–1479. doi:10.1378/chest.09-0934
38. Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Flokstra-de Blok B, Kocks J, Schultz K, van der Molen T. Health status instruments for patients with COPD in pulmonary rehabilitation: defining a minimal clinically important difference. NPJ Prim Care Respir Med. 2016;26:16041. doi:10.1038/npjpcrm.2016.41
39. Alma H, de Jong C, Tsiligianni I, Sanderman R, Kocks J, van der Molen T. Clinically relevant differences in COPD health status: systematic review and triangulation. Eur Respir J. 2018;52(3). doi:10.1183/13993003.00412-2018
40. Angst F, Aeschlimann A, Angst J. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol. 2017;82:128–136. doi:10.1016/j.jclinepi.2016.11.016
41. S.A.Doi, L.Thalib. A quality-effects model for meta-analysis. Epidemiology. 2008;19(1):94–100. doi:10.1097/EDE.0b013e31815c24e7
42. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255. doi:10.1164/rccm.201310-1863PP
43. Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105–110
44. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111–124
45. J.F.Donohue, P.W.Jones, C.Bartels, J.Marvel, P.D'Andrea, D.Banerji, D.G.Morris, F.Patalano, R.Fogel. Correlations between FEV1 and patient-reported outcomes: a pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2018;49:11–19. doi:10.1016/j.pupt.2017.12.005
46. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709. doi:10.2147/COPD.S32675
47. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, Brusasco V, Burge PS, Calverley PM, Celli BR, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416–469. doi:10.1183/09031936.00099306
48. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40. doi:10.1183/09041950.005s1693
49. Saglam M, Vardar-Yagli N, Savci S, Inal-Ince D, Calik-Kutukcu E, Arikan H, Coplu L. Functional capacity, physical activity, and quality of life in hypoxemic patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:423–428. doi:10.2147/COPD.S78937
50. Jacome C, Marques A. Computerized respiratory sounds: novel outcomes for pulmonary rehabilitation in COPD. Respir Care. 2017;62(2):199–208. doi:10.4187/respcare.04987
51. Oliveira A, Afreixo V, Marques A. Enhancing our understanding of the time course of AECOPD managed on an outpatient basis. Int J Chron Obstruct Pulmon Dis. 2018;13:3759. doi:10.2147/COPD.S175890
52. Oliveira A, Rodrigues J, Marques A. Enhancing our understanding of computerised adventitious respiratory sounds in different COPD phases and healthy people. Respir Med. 2018;138:57–63. doi:10.1016/j.rmed.2018.03.023